Hyperuricemia: all 221 studies
Page 1 of 3. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.
- Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity RisksNot yet recruitingNCT07884903
- Mazdutide for Weight Management and Gout in Adults With ObesityNot yet recruitingNCT07824895Phase 4
- Evaluation of the Effect of Hyperuricemia on Alveolar Bone LossRecruitingNCT07666126
- Probiotic-Uricase Complex Preparation for Improving Uric Acid Metabolism in Patients With HyperuricemiaNot yet recruitingNCT07613164Not applicable
- Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic HyperuricemiaRecruitingNCT07613138Not applicable
- A Study of IN026 in Participants With Refractory GoutRecruitingNCT07587684Phase 1
- Clinical Trial of BR2251 Tablets for Patients With Primary Gout and HyperuricemiaNot yet recruitingNCT07498647Phase 2
- Chronic Kidney Disease and Metabolic Disorders in the ElderlyNot yet recruitingNCT07494526
- Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)RecruitingNCT07400549Not applicable
- HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-EffectivenessNot yet recruitingNCT07369622Phase 4
- The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and HyperuricemiaRecruitingNCT07362355Phase 2
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)RecruitingNCT07280156Phase 2
- Hyperuricemia as Early Indication of CKD Progressing in PrediabeticNot yet recruitingNCT07199205
- Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese PatientsNot yet recruitingNCT07168551
- This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering TherapyRecruitingNCT07144332
- A Study of Dotinurad Versus Allopurinol in Tophaceous GoutRecruitingNCT07089888Phase 3
- A Study of Dotinurad Versus Allopurinol in Participants With GoutRecruitingNCT07089875Phase 3
- Developing A Gout Action Plan in Primary Care Setting in SingaporeNot yet recruitingNCT07061587Not applicable
- Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT07053709
- Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic HyperuricaemiaRecruitingNCT07002762Not applicable
- Metabolically Healthy Obesity Increases the Risks of MASLD and HyperuricemiaEnrolling by invitationNCT07001865
- Effects of Fibres Combined With Probiotics on Uric Acid in an ex Vivo Fermentation ModelRecruitingNCT06981663
- Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release TabletsRecruitingNCT06966635Phase 4
- Effect of Dotinurad in Hyperuricemia With HypertensionRecruitingNCT06834230Phase 4
- Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)RecruitingNCT06824376Not applicable
- Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2RecruitingNCT06694012
- SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) TrialRecruitingNCT06674109Phase 4
- Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and HyperuricemiaRecruitingNCT06629376Phase 1
- Screening and Management of Hyperuricemia in Patients with Chronic Medical Diseases in Assiut University HospitalNot yet recruitingNCT06586229
- CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep ApneaRecruitingNCT06463561Phase 4
- Prebiotics and the Management of HyperuricemiaRecruitingNCT06420401Not applicable
- A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney DiseaseRecruitingNCT06310967Phase 1/2
- Impact of Hyperuricemia on Psoriatic ArthritisRecruitingNCT06125444
- Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial FibrillationRecruitingNCT06119802
- Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With HyperuricemiaNot yet recruitingNCT05913310Phase 4
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlareRecruitingNCT05658575Phase 2/3
- Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic DiseasesRecruitingNCT05476627
- Efficacy Study of Acupuncture on Asymptomatic HyperuricemiaRecruitingNCT05406830Not applicable
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)RecruitingNCT04752293
- Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical TrialRecruitingNCT04199325Not applicable
- Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With HyperuricemiaCompletedNCT06056570Phase 1/2Results posted
- Traditional Chinese Medicine in the Treatment of Patients With Hyperuricemia.CompletedNCT04144088Phase 2Results posted
- A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and HyperuricaemiaCompletedNCT03990363Phase 2Results posted
- A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With HyperuricemiaCompletedNCT03934099Phase 2Results posted
- Uric Acid Lowering Trial in Youth Onset T2DCompletedNCT03899883Phase 2Results posted
- Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney DiseaseTerminatedNCT03865407Phase 2Results posted
- Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric AcidCompletedNCT03648996Phase 2Results posted
- The Diet Gout TrialCompletedNCT03569020Not applicableResults posted
- A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UACompletedNCT03316131Phase 2Results posted
- Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With AlbuminuriaCompletedNCT03118739Phase 2Results posted
- Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric AcidCompletedNCT02959918Phase 2Results posted
- The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and DynamicsCompletedNCT02956278Phase 4Results posted
- Pharmacogenetics of SGLT2 InhibitorsTerminatedNCT02462421Phase 4Results posted
- Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic HyperuricemiaCompletedNCT02078219Phase 2Results posted
- Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative StatusCompletedNCT01931527Not applicableResults posted
- Effects of Hyperuricemia Reversal on Features of the Metabolic SyndromeCompletedNCT01654276Phase 4Results posted
- Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early GoutCompletedNCT01078389Phase 2Results posted
- Lowering Serum Uric Acid to Prevent Acute Kidney InjuryCompletedNCT00756964Phase 2Results posted
- Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic GoutCompletedNCT00325195Phase 3Results posted
- Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeCompletedNCT00230178Phase 3Results posted
- Magnetic Resonance Imaging in Subjects With Gouty TophiCompletedNCT00174954Results posted
- Comparison of the Effect of Allopurinol Versus Febuxostat on Serum Uric Acid in Patients With Chronic Kidney Disease Associated With HyperuricemiaActive, not recruitingNCT07850713Not applicable
- Identification and Characterization of At-risk MASLD in Turkish AdultsCompletedNCT07548970
- Long-Term Risk of Gout in Living Kidney DonorsActive, not recruitingNCT07546643
- Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy SubjectsActive, not recruitingNCT07366749Not applicable
- Effectiveness of Digital Health Intervention on Community Health Care in Middle-aged and Older Population in TaiwanCompletedNCT07238257Not applicable
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsActive, not recruitingNCT07116746Phase 2
- Relationship Between Intestinal Flora Changes and Hyperuricemia Under Chronic Psychological StressCompletedNCT06984575
- Clinical Effect Observation of Barley Green Intervention in Hyperuricemia Population and Related Mechanism Study of Xanthine OxidaseCompletedNCT06876909Not applicable
- A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaActive, not recruitingNCT06859073Phase 1
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)CompletedNCT06846515Phase 3
- PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal FunctionActive, not recruitingNCT06729853Phase 1/2
- Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With HyperuricemiaCompletedNCT06718062Phase 4
- SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese SubjectsCompletedNCT06678581Phase 1
- Possible Pharmacological Effect of Quercetin in the Management of Hyperuricemia - Results From Real-life Clinical StudiesCompletedNCT06652035
- Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and HyperuricemiaActive, not recruitingNCT06603142Phase 2/3
- Quercetin as Possible Supportive Therapy for Mild to Moderate HyperuricemiaCompletedNCT06591767Not applicable
- A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout SubjectsCompletedNCT06501534Phase 2
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)CompletedNCT06439602Phase 3
- The Effect of Exercise at Different Time Intervals on HyperuricemiaCompletedNCT06315569Not applicable
- Effect of Increased Daily Water Intake in Patients With HyperuricemiaCompletedNCT06315543Not applicable
- PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT IntervalCompletedNCT06196580Phase 1
- Effect of Tigulixostat on the Pharmacokinetics of TheophyllineCompletedNCT06189404Phase 1
- Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy SubjectsCompletedNCT06168929Phase 1
- The Efficacy of Amway Uric Acid Lowering Product on HyperuricemiaStatus unknownNCT06084585Not applicable
- Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy SubjectsCompletedNCT05954169Phase 1
- Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout PatientsCompletedNCT05586971Phase 3
- Tigulixostat, Phase 3 Study, Placebo Controlled in Gout PatientsCompletedNCT05586958Phase 3
- Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients with HyperuricemiaActive, not recruitingNCT05574036Phase 2
- Distribution of Immune Cells and Their Subtypes in Peripheral Blood of GoutActive, not recruitingNCT05522504
- Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and HyperuricemiaStatus unknownNCT05513976Phase 2
- Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia PatientsCompletedNCT05504083Phase 2
- Orlistat Reduces Uric Acid in Overweight/Obese Patients With HyperuricemiaCompletedNCT05496075Phase 4
- Patients With Asymptomatic Hyperuricemia Have Stronger Local Inflammatory Response and Worse Outcome After Total Knee ArthroplastyStatus unknownNCT05476367
- Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD PatientsCompletedNCT05474560Phase 4
- Effect of Aquatic Exercise and Traditional Physical Therapy on Gout in Hypertensive Menopausal Women With HyperuricemiaStatus unknownNCT05454423Not applicable
- Imagery as Biomarker of GoutActive, not recruitingNCT05434858Not applicable
- Effect of Prebiotics on HyperuricemiaStatus unknownNCT05385003Not applicable
- A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in AdultsStatus unknownNCT05347498Phase 1
- Flow Mediated Dilation in Association With HyperuricemiaStatus unknownNCT05342285